Profusa (NVACW) Net Income towards Common Stockholders (2022 - 2026)

Profusa (NVACW) reported Net Income towards Common Stockholders of -$4.0 million for Q1 2026, down 259.31% on a YoY basis from $2.5 million in Q1 2025, and up 13.43% quarter-over-quarter from -$4.6 million in Q4 2025.

Profusa (NVACW) Net Income towards Common Stockholders (2022 - 2026) Analysis & Trends

Profusa has reported Net Income towards Common Stockholders for 5 years, with the latest figure at -$4.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Net Income towards Common Stockholders fell 259.31% year-over-year to -$4.0 million; the trailing twelve-month figure through Mar 2026 stood at -$38.7 million (down 329.33% YoY), and the FY2025 full-year result was -$30.2 million, down 246.43% from the prior year.
  • Net Income towards Common Stockholders for Q1 2026 stood at -$4.0 million, up from -$4.6 million in the prior quarter.
  • The five-year high for Net Income towards Common Stockholders was $2.9 million in Q1 2022, with the low at -$21.9 million in Q3 2025.
  • Historically, Net Income towards Common Stockholders has averaged -$2.7 million across 5 years, with a median of -$397487.0 in 2024.
  • Annual changes were most pronounced in 2024 — Net Income towards Common Stockholders jumped 129.48% — and 2025, when it slumped 24095.09%.
  • Profusa's Net Income towards Common Stockholders stood at -$3.7 million in 2022, then jumped by 105.74% to $212692.0 in 2023, then plunged by 3672.63% to -$7.6 million in 2024, then surged by 38.83% to -$4.6 million in 2025, then advanced by 13.43% to -$4.0 million in 2026.
  • The last three Net Income towards Common Stockholders figures came in at -$4.0 million (Q1 2026), -$4.6 million (Q4 2025), and -$21.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 1.08 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 745.00 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 1.15 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 187,319.30
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 199.50 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 411.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 Profusa - - - -4.02 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -4.02 Mn
Dec 31, 2025 -4.65 Mn
Sep 30, 2025 -21.88 Mn
Jun 30, 2025 -8.20 Mn
Mar 31, 2025 -1.12 Mn
Dec 31, 2024 -7.60 Mn
Sep 30, 2024 91,177.00
Jun 30, 2024 -397,487.00
Mar 31, 2024 -820,277.00
Dec 31, 2023 212,692.00
Sep 30, 2023 -309,328.00
Jun 30, 2023 134,623.00
Mar 31, 2023 336,660.00
Dec 31, 2022 -3.71 Mn
Sep 30, 2022 1.38 Mn
Jun 30, 2022 951,832.00
Mar 31, 2022 2.91 Mn